These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3648425)

  • 41. Primary intestinal candidiasis in an immunocompetent patient.
    Cheema AW; Krishnamoorthi K; Singh M; Kanhere G; Khan A; Krishnamoorthi S; Chan C; Soni A
    Am J Gastroenterol; 2000 Nov; 95(11):3312-3. PubMed ID: 11095367
    [No Abstract]   [Full Text] [Related]  

  • 42. [Diagnosis and treatment of intestinal candidiasis].
    Sheviakov MA
    Ter Arkh; 2003; 75(11):77-9. PubMed ID: 14708450
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of chronic bacterial infections of the small intestine. Chronic bacterial overgrowth, tropical sprue and Whipple's disease].
    Rambaud JC; Ngô Y
    Ann Gastroenterol Hepatol (Paris); 1993; 29(4):189-97. PubMed ID: 7694539
    [No Abstract]   [Full Text] [Related]  

  • 44. [Enterotoxin production as a diagnostic test in intestinal dysbacterioses ].
    Sheveleva SA; Kuvaeva IB; Fluer FS; Kuznetsova GG
    Vopr Pitan; 2002; 71(4):23-6. PubMed ID: 12462951
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The lactulose breath test (LBT): modified, but still a lot of hot air?
    Lieb JG; Draganov PV
    J Clin Gastroenterol; 2008; 42(10):1067-9. PubMed ID: 18936642
    [No Abstract]   [Full Text] [Related]  

  • 46. [Pseudomembranous colitis and "intestinal sepsis" as a consequence of dysbacteriosis due to antibiotics].
    Eriukhin IA; Shliapnikov SA; Lebedev VF; Ivanov GA
    Vestn Khir Im I I Grek; 1997; 156(2):108-11. PubMed ID: 9235747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of efficacy of the use of coli-Proteus bacteriophage in intestinal dysbacteriosis in premature infants].
    Litvinova AM; Chtetsova VM; Kavtreva IG
    Vopr Okhr Materin Det; 1978 Sep; 23(9):42-4. PubMed ID: 716289
    [No Abstract]   [Full Text] [Related]  

  • 48. [Correction of intestinal dysbacteriosis with biological preparations in acute leukemia].
    Tolkacheva TV; Abakumov EM; Martynova VA; Golosova TV
    Probl Gematol Pereliv Krovi; 1981 Jul; 26(7):29-33. PubMed ID: 7279892
    [No Abstract]   [Full Text] [Related]  

  • 49. [Role of intestinal dysbacteriosis in the pathology of young children].
    Serebriakova NN; Kaz'mina GK
    Vopr Okhr Materin Det; 1972 May; 17(5):17-9. PubMed ID: 5029745
    [No Abstract]   [Full Text] [Related]  

  • 50. Dirty pigs beat disease.
    Gilbert N
    Nature; 2009 Dec; 462(7273):558. PubMed ID: 19956233
    [No Abstract]   [Full Text] [Related]  

  • 51. [Microecological disorders in the intestines of patients with chronic kidney failure and the arterial hypertension syndrome].
    Bobrov VA; Karpov PF
    Ter Arkh; 1993; 65(6):41-3. PubMed ID: 8378848
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Intestinal dysbacteriosis: current aspects of studying the problem, principles of diagnosis and treatment].
    Ardatskaia MD; Dubinin AV; Minushkin ON
    Ter Arkh; 2001; 73(2):67-72. PubMed ID: 11338863
    [No Abstract]   [Full Text] [Related]  

  • 53. [Natural immunity indices in dysbacteriosis].
    Martynova VA; Tolkacheva TV; Golosova TV
    Probl Gematol Pereliv Krovi; 1979 Mar; 24(3):34-8. PubMed ID: 432226
    [No Abstract]   [Full Text] [Related]  

  • 54. [Facultatively pathogenic microbes in the intestines].
    Srámová H; Svandová E; Prajzlerová V
    Cesk Epidemiol Mikrobiol Imunol; 1983 Mar; 32(2):96-102. PubMed ID: 6220826
    [No Abstract]   [Full Text] [Related]  

  • 55. [Hepon, promoter of local immunity in the complex therapy of dysfunctional microflora in bowel disorders].
    Parfenov AI; Ruchkina IN
    Eksp Klin Gastroenterol; 2003; (3):66-9, 118. PubMed ID: 14556551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The prevention and treatment of a Candida-mycosis type of dysbacteriosis in chronic bronchitis in older patients].
    Khrystych TM; Shestakova KH; Krakov'iats'ka NV
    Lik Sprava; 1999; (3):109-11. PubMed ID: 10474952
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effectiveness of acipole in prevention of enteric dysbacteriosis due to antibacterial therapy].
    Oleĭnichenko EV; Mitrokhin SD; Nonikov VE; Minaev VI
    Antibiot Khimioter; 1999; 44(1):23-5. PubMed ID: 10095921
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Rapid immunochemical tests for the diagnosis of acute enteric infections].
    Zaĭko SD
    Klin Lab Diagn; 2011 Jan; (1):53-5. PubMed ID: 21427947
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The diagnosis of intestinal dysbacteriosis by the spectrum of fecal amino acids].
    Bagriantseva OV; Kalamkarova LI; Rokutova AV; Aznametova GK; Idrisova RS
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (4):67-9. PubMed ID: 10852057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phage therapy for the treatment of human intestinal bacterial infections: soon to be a reality?
    Brüssow H
    Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):785-788. PubMed ID: 28612636
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.